Aptevo Therapeutics Inc. (APVO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$26.07M

Year ended 2025-12-31

-$26.69M

Trailing 12 months to 2026-06-30

2015-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$26.07M	n/m	2026-03-26, From 2025-01-01
2024-12-31	-$24.25M	n/m	2026-03-26, From 2024-01-01
2023-12-31	-$28.31M	n/m	2025-02-14, From 2023-01-01
2022-12-31	-$27.74M	n/m	2024-03-05, From 2022-01-01
2021-12-31	-$20.26M	n/m	2023-03-30, From 2021-01-01
2020-12-31	-$26.09M	n/m	2022-03-24, From 2020-01-01
2019-12-31	-$38.73M	n/c	2021-03-31, From 2019-01-01
2018-12-31	-$49.27M	n/m	2020-03-25, From 2018-01-01
2017-12-31	-$50.82M	n/m	2019-03-18, From 2017-01-01
2016-12-31	-$135.41M	n/c	2018-03-13, From 2016-01-01
2015-12-31	-$58.19M	n/a	2017-03-31, From 2015-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
Aptevo Therapeutics Inc. (APVO)	2025-12-31	-$26.07M	n/m
Skye Bioscience, Inc. (SKYE)	2025-12-31	-$57.44M	n/m
Biofrontera Inc. (BFRI)	2025-12-31	-$11.21M	n/m
Neuphoria Therapeutics Inc. (NEUP)	2026-06-30	-$15.79M	n/m
CASI Pharmaceuticals, Inc. (CASIF)	2025-12-31	-$43.81M	n/m
Integrated Biopharma Inc (INBP)	2026-06-30	-$2.41M	n/m
Onconetix, Inc. (ONCO)	2025-12-31	-$17.84M	n/m
Talphera, Inc. (TLPH)	2024-12-31	-$15.25M	n/m
Veru Inc. (VERU)	2025-09-30	-$24.60M	n/m

Compare APVO, SKYE, BFRI, NEUP side by side · Screen every company in Pharmaceutical Preparations ↗